FDA Recall Open, Classified

Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform

Recall: Z-1255-2023 · Initiated February 14, 2023

Recall

Recall Number
Z-1255-2023
Event Number
91704
Firm
Fenwal Inc
FEI Number
3004548776
Product Code
LKN
Status
Open, Classified
Root Cause
Process control
Initiated
February 14, 2023
Posted
March 15, 2023
Address
3 Corporate Dr, Ste 300, Lake Zurich, IL, 60047-8930

Description

Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform

Reason

Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.

Action

Fresenius Kabi notified customers on 02/14/2023 via FedEx overnight delivery. Customers were instructed to evaluate affected inventory on site for potential continued use according to the conditions in the letter, inform potential users of affected product within the facility and any customers if further distributed, complete and return the acknowledgment form, and report any issues.

Distribution

Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.

Quantity

6,564 units